← All trials
NCT03052010
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 6, 2017
- Primary completion
- Feb 1, 2021
- Completion date
- Aug 1, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 4800
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of WashingtonLead sponsor
- University of WashingtonOverall official - principal investigator
- University of WashingtonReponsible party - principal investigator
- University of WashingtonStudy director
- Kenya Medical Research InstituteCollaborator
- National Institute of Mental Health (NIMH)Collaborator
- Kenya National AIDS & STI Control ProgrammeCollaborator
- Bill and Melinda Gates FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.